| Company Name: | Aceto Corporation | | Ticker Symbol: | ACET | | | WWW Address: | www.aceto.com |
| CEO: | Salvatore J. Guccione | | No. of Employees: | 233 |
| Common Issue Type: | CS | | Business Description: | Aceto Corporation is engaged in the sourcing, quality assurance, regulatory support, marketing and distribution of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and crop protection products.
|
| | | Industry Information: | CHEMICALS - Chemicals - Major Diversified [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 11.79 |  -0.08 | 9.11 | 12.17 | 11.9 | 12.08 | 11.50 | 75271 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 323.0 | 27.4 | 1.10 | 0.63 | 0.20 | 15.4 | 1.9 | 12.08 - 8.21 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 11.86 | $ | | PE Ratio - LTM | 15.4 | |
| Market Capitalisation | 323.0 | mil |
| Latest Shares Outstanding | 27.4 | mil |
| Earnings pS (EPS) | 0.63 | $ |
| Dividend pS (DPS) | 0.20 | ¢ |
| Dividend Yield | 1.9 | % |
| Dividend Payout Ratio | 32 | % |
| Revenue per Employee | 1,907,245 | $ |
| Effective Tax Rate | 31.4 | % |
| Float | 25.6 | mil |
| Float as % of Shares Outstanding | 94.2 | % |
| Foreign Sales | 155 | mil |
| Domestic Sales | 290 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 12.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 20.8 | % |
| EBITDA Margin | 7.9 | % |
| Pre-Tax Profit Margin | 6.5 | % |
| Assets Turnover | 1.5 | % |
| Return on Assets (ROA) | 6.3 | % |
| Return on Equity (ROE) | 11.3 | % |
| Return on Capital Invested (ROCI) | 9.4 | % |
| Current Ratio | 2.5 | |
| Leverage Ratio (Assets/Equity) | 1.8 | |
| Interest Cover | 15.8 | |
| Total Debt/Equity (Gearing Ratio) | 0.24 | |
| LT Debt/Total Capital | 16.0 | % |
| Working Capital pS | 5.01 | $ |
| Cash pS | 1.29 | $ |
| Book-Value pS | 6.76 | $ |
| Tangible Book-Value pS | 4.03 | $ |
| Cash Flow pS | 1.02 | $ |
| Free Cash Flow pS | 0.43 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.75 | |
| Price/Tangible Book Ratio | 2.94 | |
| Price/Cash Flow | 11.7 | |
| Price/Free Cash Flow | 27.5 | |
| P/E as % of Industry Group | 88.0 | % |
| P/E as % of Sector Segment | 67.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 05/08/2013 |
| Dividend Ex-Date | 06/11/2013 |
| Dividend Record Date | 06/13/2013 |
| Dividend Pay Date | 06/24/2013 |
| Dividend Amount | 55 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.22 |
| Current Dividend Yield | 1.9 |
| 5-Y Average Dividend Yield | 2.9 |
| Payout Ratio | 32.0 |
| 5-Y Average Payout Ratio | 54.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.6 | 103 | 2,166 | 2,434 |
| 4 Weeks | 12.08 | 10.00 | 10.28 | 15.4 | 110 | 1,630 | 26,085 |
| 13 Weeks | 12.08 | 10.00 | 10.50 | 13.0 | 103 | 1,047 | 62,793 |
| 26 Weeks | 12.08 | 9.48 | 9.87 | 20.2 | 102 | 1,085 | 131,228 |
| 52 Weeks | 12.08 | 8.21 | 8.25 | 43.8 | 114 | 1,096 | 268,545 |
| YTD | 12.08 | 9.60 | - | 18.0 | 101 | 1,078 | 103,451 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 11.40 | 10.99 | 10.73 | 10.32 | 9.96 | 1.10 | 1.68 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 7.15 | 75.6 | 11.84 |
| Income | 9.23 | 18.0 | 51.01 |
| Dividend | -0.55 | 0.7 | 6.63 |
| Capital Spending | 10.82 | NA | -11.43 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 9.31 | NA | 52.68 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 12.9 | 24.3 | 7.7 |
| Earnings % | 30.2 | 41.2 | 89.4 |
| EPS % | 26.5 | 40.0 | 85.3 |
| EPS $ | 0.13 | 0.08 | 0.29 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 39.54 |
| Current Ratio | 2.6 |
| Quick Ratio (Acid Test) | 1.4 |
| Liquidity Ratio (Cash) | 0.36 |
| Receivables Turnover | 5.3 |
| Average Collection Period | 68 |
| Working Capital/Equity | 70.4 |
| Working Capital pS | 4.39 |
| Cash-Flow pS | 0.89 |
| Free Cash-Flow pS | 0.23 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.87 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 43.9 |
| Total Debt/Equity (Gearing Ratio) | 0.27 |
| LT Debt/Equity | 0.23 |
| LT Debt/Capital Invested | 27.8 |
| LT Debt/Total Liabilities | 29.7 |
| Interest Cover | 10.4 |
| Interest/Capital Invested | 1.16 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 7.24 |
| Tobin's Q Ratio | 1.09 |
| Current P/E Ratio - LTM | 15.40 |
| Enterprise Value (EV)/EBITDA | 13.30 |
| Enterprise Value (EV)/Free Cash Flow | 121.51 |
| Dividend Yield | 1.9 |
| Price/Tangible Book Ratio - LTM | 2.94 |
| Price/Book Ratio - LTM | 1.75 |
| Price/Cash Flow Ratio | 11.7 |
| Price/Free Cash Flow Ratio - LTM | 27.5 |
| Price/Sales Ratio | 0.67 |
| P/E Ratio (1 month ago) - LTM | 13.5 |
| P/E Ratio (26 weeks ago) - LTM | 14.3 |
| P/E Ratio (52 weeks ago) - LTM | 13.5 |
| 5-Y High P/E Ratio | 33.4 |
| 5-Y Low P/E Ratio | 7.2 |
| 5-Y Average P/E Ratio | 17.9 |
| Current P/E Ratio as % of 5-Y Average P/E | 86 |
| P/E as % of Industry Group | 88.0 |
| P/E as % of Sector Segment | 67.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 15.4 |
| PER SHARE FIGURES |
| LT Debt pS | 1.45 |
| Current Liabilities pS | 2.73 |
| Tangible Book Value pS - LTM | 4.03 |
| Book Value pS - LTM | 6.76 |
| Capital Invested pS | 7.56 |
| Cash pS - LTM | 1.29 |
| Cash Flow pS - LTM | 1.02 |
| Free Cash Flow pS - LTM | 0.43 |
| Earnings pS (EPS) | 0.63 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 1.38 |
| Free Cash Flow Margin 5YEAR AVG | 0.06 |
| Net Profit Margin | 3.8 |
| Net Profit Margin - 5YEAR AVRG. | 2.9 |
| Equity Productivity | 2.65 |
| Return on Equity (ROE) | 10.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 7.3 |
| Capital Invested Productivity | 2.15 |
| Return on Capital Invested (ROCI) | 8.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 6.3 |
| Assets Productivity | 1.50 |
| Return on Assets (ROA) | 5.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 4.3 |
| Gross Profit Margin | 20.8 |
| Gross Profit Margin - 5YEAR AVRG. | 18.3 |
| EBITDA Margin - LTM | 7.9 |
| EBIT Margin - LTM | 6.9 |
| Pre-Tax Profit Margin | 5.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 4.6 |
| Effective Tax Rate | 31.4 |
| Effective Tax Rate - 5YEAR AVRG. | 37.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 145 |
| Revenue per Employee | 1,907,245 |
| Net Income per Employee | 72,880 |
| Average Collection Period | 63 |
| Receivables Turnover | 5.3 |
| Day's Inventory Turnover Ratio | 82 |
| Inventory Turnover | 4.4 |
| Inventory/Sales | 19.1 |
| Accounts Payble/Sales | 9.45 |
| Assets/Revenue | 0.67 |
| Net Working Capital Turnover | 3.76 |
| Fixed Assets Turnover | 4.14 |
| Total Assets Turnover | 1.5 |
| Revenue per $ Cash | 17.87 |
| Revenue per $ Plant | 37.97 |
| Revenue per $ Common Equity | 2.65 |
| Revenue per $ Capital Invested | 2.15 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 12.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 12.7 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
